Clinical Trial: Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07610395) titled 'Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD' on May 12.

Brief Summary: Compare the safety and efficacy of two different oral vapendavir doses with placebo in order to determine the appropriate dose of vapendavir to reduce the severity and/or duration of respiratory symptoms associated with RV infections in patients with COPD.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Rhinovirus Infection

Intervention: DRUG: VPV 1000 mg

Vapendavir 1000 mg

DRUG: VPV 500 mg

Vapendavir 500 mg

OTHER: Placebo

Placebo

Recruitment Status: R...